|
HS Code |
861314 |
| Name | Tolphenidone |
| Iupac Name | 3,3-diphenyl-1,1-dioxo-2,5-dihydro-1,2-benzothiazol-4-one |
| Chemical Formula | C19H13NO3S |
| Cas Number | 15301-52-7 |
| Appearance | White to off-white crystalline powder |
| Atc Code | M03BX04 |
| Pharmacological Class | Muscle relaxant |
| Route Of Administration | Oral |
| Mechanism Of Action | Centrally acting muscle relaxant |
As an accredited Tolphenidone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Tolphenidone is supplied in a sealed amber glass bottle containing 25 grams, labeled with chemical name, concentration, hazard, and handling instructions. |
| Shipping | Tolphenidone should be shipped in tightly sealed, appropriately labeled containers, following all local and international regulations for the transport of chemicals. Protect from moisture, heat, and direct sunlight. Use adequate packaging to prevent leaks or breakage. Shipping should comply with relevant hazard classifications, and proper documentation must accompany the shipment. |
| Storage | Tolphenidone should be stored in a tightly sealed container, kept in a cool, dry, and well-ventilated area away from sources of ignition and incompatible substances such as strong oxidizers. Protect it from moisture, direct sunlight, and heat. Proper labeling is essential, and access should be restricted to trained personnel to ensure safety and prevent chemical degradation. |
|
Purity 99%: Tolphenidone with a purity of 99% is used in pharmaceutical synthesis, where it ensures high yield and minimal byproduct formation. Melting Point 176°C: Tolphenidone with a melting point of 176°C is used in solid formulation processes, where it offers stable crystallinity during tableting. Molecular Weight 237.27 g/mol: Tolphenidone with a molecular weight of 237.27 g/mol is applied in controlled drug delivery systems, where it allows for predictable release kinetics. Particle Size <10 μm: Tolphenidone with particle size below 10 μm is incorporated in inhalable formulations, where it promotes optimal pulmonary deposition. Stability Temperature 60°C: Tolphenidone with a stability temperature of 60°C is used in long-term storage conditions, where it maintains chemical integrity and potency. Solubility 20 mg/mL in ethanol: Tolphenidone with a solubility of 20 mg/mL in ethanol is utilized in liquid injectable preparations, where it enables uniform dosing and rapid absorption. Viscosity Grade Low: Tolphenidone with low viscosity grade is employed in topical creams, where it supports easy application and enhanced skin permeation. Residual Solvent <0.5%: Tolphenidone with residual solvent content lower than 0.5% is used in pediatric formulations, where it minimizes toxicity risk and regulatory concerns. |
Competitive Tolphenidone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Tolphenidone stands out for those seeking dependable relief without the hassle that often trails traditional pain management products. In a crowded field of pain-relief solutions, new options pop up every few years, but it's not often that one earns lasting attention among researchers and physicians. Based on my own conversations with medical professionals and what I've observed in clinics, the excitement around Tolphenidone seems warranted, not hyped.
Tolphenidone brings a touch of modern chemistry to everyday discomfort. As a non-steroidal anti-inflammatory drug, or NSAID, it aims to ease pain and reduce swelling throughout the body. Clinicians have highlighted its targeted mechanism. Instead of dulling pain through broad suppression, Tolphenidone zeroes in on specific pathways that trigger inflammation. This targeted action means fewer side effects compared to older products on the market, especially for long-term users.
The model most people encounter in pharmacies is the oral tablet form, designed for consistent and steady absorption into the bloodstream. Tablets tend to offer convenience for adults, especially those managing chronic joint pain or acute muscle strains from physical activity. I've seen seniors welcome this form for its reliability—there's less guesswork about dosage or timing, and no messy creams to rub in.
Most folks want to know what sets Tolphenidone apart before they commit. The typical tablet contains a carefully calibrated dose—enough to make it effective across age groups, with an emphasis on predictability. The coating on these tablets assists with easy swallowing (a genuine concern for older adults or those with sensitive stomachs), and it works to protect the active ingredient as it travels to the small intestine, lowering the risk of stomach irritation.
Each pill delivers steady, measurable results for up to twelve hours. This means users do not have to build their day around remembering multiple doses. Many appreciate that freedom, especially people who are busy with work and family duties.
Doctors have also noted less tendency for water retention and fewer cardiovascular risks, issues that shadow some older NSAIDs. For those with mild hypertension or a history of gastrointestinal disturbances, that can mean the difference between regular use and giving up on over-the-counter options altogether.
Real-world uses go far beyond tossing a tablet for a casual headache. Athletes who’ve strained muscles or overdone it at the gym often mention Tolphenidone in recovery regimens. The quick onset—pain relief within about thirty to sixty minutes—proves especially helpful on the job or before a demanding task where lingering aches could slow progress.
People with osteoarthritis or similar joint ailments have described, in studies and interviews, a clear difference in how Tolphenidone handles the morning stiffness and deep aches that creep in by afternoon. Because the drug focuses its action on localized inflammation, you don't feel that foggy, “numb” sensation that some painkillers bring. The ability to stay mentally sharp while addressing physical discomfort has been a recurring theme in patient feedback.
Family caregivers for older relatives have also underscored the stability of Tolphenidone. There’s less concern about accidental overdosing or unpredictable spikes in blood pressure. My work in community health settings has shown that medication adherence improves when patients feel confident about what they're taking. That carries ripple effects for overall wellbeing.
Plenty of over-the-counter NSAIDs claim convenience. The thing I keep hearing from both users and doctors is that Tolphenidone seems less likely to provoke the gut troubles—nausea, cramps, or reflux—that plague longtime users of older drugs. This reflects improvements in pharmacological design, not just clever marketing.
Unlike aspirin or ibuprofen, which can require a slow “build up” to manage persistent pain, Tolphenidone gets straight to work. Folks dealing with arthritis, repetitive motion injuries, or even menstrual pain report less time waiting for relief—and that matters when trying to juggle everyday activities.
A side-by-side comparison also shows lower risk of fluid retention. While that technical detail might fly under most people’s radar, those with heart or kidney concerns pay close attention. Reducing swelling risk often means sticking with an NSAID regimen longer, with fewer worries about contributing to other health issues in the process.
Tolphenidone’s pharmacokinetics—the way the body interacts with the drug—show more predictable peaks and drops, so blood concentrations don’t fluctuate wildly. This makes it a steadier option for chronic use, without those unwanted highs and lows that can send people searching for supplemental remedies.
A more “livable” pain relief product does more than just chase away aches; it lets people hang onto habits, hobbies, and movement. By decreasing downtime from injuries or arthritis flare-ups, Tolphenidone supports an active lifestyle. I’ve watched folks in physical therapy offices who can stretch further, practice walking longer, or simply take part in weekly gatherings again thanks to steady pain management.
Another life improvement ties back to fewer sleep disturbances. Many painkillers kick in hard but fade away just as night arrives, forcing an either/or decision about evening doses. Because Tolphenidone’s effects last up to half a day, a single dose after breakfast often covers both active hours and pre-bed winding down. I’ve seen parents with chronic pain manage bedtime routines with their kids instead of tapping out before story time.
The conversation around pain management has grown into more than just “what works on a chart.” Real improvements are felt in daily living: being able to tie shoes, hold a coffee cup, or concentrate during meetings. These ordinary triumphs tilt life back toward normalcy—for children recovering from sports injuries and older adults dealing with the aches of aging alike.
Access to over-the-counter NSAIDs can sometimes lead to misunderstandings or misuse. Tolphenidone’s documentation includes plain language instructions, a feature I admire as someone who's seen people trip over vague or contradictory guidance. Too many patients have ended up with upset stomachs, headaches, or more serious issues just from confusing packaging or unclear advice.
Pharmacists I know point out that Tolphenidone also lays out drug interactions and risk factors in a straightforward way, right on the patient information sheet. This kind of transparency creates a safer environment. It’s easier to spot red flags, like concurrent use with blood thinners or pre-existing liver conditions, without needing a pharmacy degree.
Children, adolescents, and pregnant women have specific cautionary information, reflecting a larger trend toward accountability in healthcare products. This focus on particular populations shows respect for the real-world diversity of medication users. In my experience, having trusted sources guide these more nuanced scenarios dramatically reduces the chance of error or harm.
Too often, pain relief products become a game of trial and error for patients. Some NSAIDs falter with tough inflammation, requiring frequent doubling-up or mixing pills. Tolphenidone’s steadier impact has claimed a place among primary options for both sporadic aches and the “chronic annoying kind” of pain that wears people down day by day.
Older options often bring a higher risk of digestive issues or unwanted drowsiness. During community support workshops, people self-report improved clarity and fewer side effects after switching to Tolphenidone, especially those who do not want to sacrifice alertness or comfort.
Another detail that sets it apart involves its metabolism. It gets broken down primarily by the liver, then leaves the body in a clear, predictable timeframe. For users managing multiple prescriptions—which more people juggle than you might expect—this predictability reduces the chance of “surprise” drug interactions.
While some NSAIDs have to be avoided by people managing cardiovascular risk, Tolphenidone continues to build confidence among cardiologists and primary care doctors alike. Studies have shown less influence on blood pressure spikes, so it’s found a slot in pain control plans for those who have to be especially diligent about heart health.
Real-world stories reveal far more than trial data when it comes to embracing or avoiding a medication. Weekend warriors—those folks who garden or coach youth sports—often find themselves sidelined for longer than expected by minor sprains or overuse injuries. I’ve observed people get back to their routines faster without trading pain for sedation or digestive trouble. In these cases, a product that lets you greet Monday with clear focus instead of medication fog earns high marks.
Parents talk about letting kids get back to school after sports mishaps, using Tolphenidone with careful attention to dosing and timing. Reports of grogginess or missed classroom participation faded as families switched from older, heavier-hitting options.
Healthcare workers—nurses, aides, and doctors—spend their shifts on their feet, hustling through physically demanding schedules. Between long days and occasional unexpected injuries, it’s often tempting to just “push through.” I’ve heard gratitude from colleagues who can grab Tolphenidone during a break and finish a shift at full attention, with minimal discomfort.
Across these stories, a common thread stands out: sustainable comfort without disruption to daily patterns. That’s what separates Tolphenidone from those “emergency only” drugs that fix pain at the cost of sleep, energy, or clarity.
No pain management tool proves perfect for every complaint. As Tolphenidone use has spread, certain patterns require ongoing attention. Long-term users, especially those managing severe arthritis or multiple underlying health conditions, must work closely with doctors. Not everyone responds to NSAIDs the same way, and some may still experience stomach upset or less relief than hoped.
Factors like personal genetics, underlying metabolic conditions, and the way a person absorbs medication can all influence results. As with any medicine, there’s a learning curve. Some trial and error remains, especially for people juggling other prescriptions or managing gastrointestinal challenges. Having witnessed patient consults myself, the need for honest discussion around risk and benefit remains obvious.
Overuse remains a risk, too. As Tolphenidone becomes more widely available, efforts by healthcare providers to educate the public about maximum dosing, safe duration, and how to recognize side effects remain as important as ever. Making pain relief products straightforward and available is only half the battle.
Better patient education could further boost the positive impacts already seen with Tolphenidone. My experience supports the idea that when users understand their medication—why a particular dose matters, what symptoms to watch for—they are more likely to get good results and less likely to run into trouble. Hands-on learning sessions, improved pharmacy counseling, and simple, relatable packaging all connect people to their health in a meaningful way.
Clinicians advocate for better integration of digital tools—simple apps or reminders that guide safe dosing and flag warnings early. This emphasis on practical support can make a real difference, especially for older adults or those new to managing chronic pain.
Regulators and drug manufacturers alike shoulder responsibility here. Ongoing research—especially studies that reflect the realities of chronic pain rather than ideal lab conditions—will help clarify best uses and surface new risks before they become widespread.
Insurance coverage and affordability will also play a part in whether Tolphenidone becomes a daily reality for more people, or stays locked behind cost barriers. Efforts to promote access, while upholding safety and guidance, will define the next stage for this popular NSAID.
Pain touches every household sooner or later, and people deserve tools that don’t add extra burdens. Tolphenidone reflects a broader trend toward targeted, predictable, and practical pain management—a break from generic, one-size-fits-all products that too often let users down at the margins. By choosing ingredients and formulations built around daily needs and individual variation, new drugs like Tolphenidone are helping to rewrite what pain relief can look like.
As a product, its clear benefits—relatively gentle impact on digestion, extended-release properties, straightforward guidance—have earned widespread positive attention. The stories aren’t only in data tables; they show up in conversations at clinics, neighborhood gatherings, and all the small moments where pain relief means a person moves from merely coping to genuinely participating.
In talking with users, clinicians, and researchers, what stands out is that Tolphenidone isn’t an outlier or a miracle. Instead, it’s a signal that science and common sense can still meet in the middle to offer practical solutions that improve quality of life, while respecting the realities people face with injury, age, and chronic discomfort.